Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Crystal Englert

Physician Assistant Rochester, NY Physician Assistant

NPI 1609861533 CMS profile 11196686

120 Erie Canal Dr, Ste 200, Rochester, NY 14626

Open in the dashboard

General payments

$3,977

237 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Crystal Englert of Rochester, NY is reported in the CMS Open Payments database as having received $3,977 across 237 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,006 76
2024 General $1,164 71
2023 General $788 39
2022 General $799 43
2021 General $220 8

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Crystal Englert
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Crystal Englert were reported at $1,006. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Crystal Englert Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $220 $132 $37–$438 $132
2022 $799 $155 $48–$522 $149
2023 $788 $167 $52–$557 $160
2024 $1,164 $178 $55–$600 $164
2025 $1,006 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $656 42 payments
  2. Janssen Biotech, Inc. $634 19 payments
  3. Genzyme Corporation $558 24 payments
  4. Novartis Pharmaceuticals Corporation $551 76 payments
  5. UCB, Inc. $420 19 payments
  6. Lilly USA, LLC $322 16 payments
  7. Dermavant Sciences, Inc. $132 7 payments
  8. Amgen Inc. $121 5 payments
  9. E.R. Squibb & Sons, L.L.C. $113 5 payments
  10. Pfizer Inc. $109 6 payments
  11. Other $361 18 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $3,648 232 payments
  2. Education $329 5 payments
Products named General payments · program years 2021–2025
  1. DUPIXENT $787 32 payments
  2. TREMFYA $634 19 payments
  3. Bimzelx $387 17 payments
  4. COSENTYX Dermatology $346 53 payments
  5. TALTZ $322 16 payments
  6. RINVOQ $271 13 payments
  7. SKYRIZI $266 16 payments
  8. COSENTYX Immunology $183 16 payments
  9. EBGLYSS $139 6 payments
  10. VTAMA $132 7 payments
  11. Other $1,158 71 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 21 drugs

Part D claims

942

Median for Physician Assistant: 241

Drug cost

$822,681

Median for Physician Assistant: $4,110

Branded share of claims

8.6%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Skyrizi Pen Risankizumab-Rzaa Brand 19 $440,995
Cosentyx Unoready Pen Secukinumab Brand 21 $310,181
Dupixent Pen Dupilumab Brand 12 $43,962
Tacrolimus Generic 44 $5,419
Clobetasol Propionate Generic 104 $3,845
Econazole Nitrate Generic 76 $3,317
Fluocinonide Generic 44 $2,562
Metronidazole Generic 38 $2,155
Clindamycin Phosphate Generic 40 $1,832
Ketoconazole Generic 87 $1,697

The 10 drugs with the highest cost, of 21 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 23 billing codes

Paid by Medicare

$30,680

Medicare's payments for the services billed

Medicare patients

192

Average age 72

Services billed

882

110 women, 82 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 67%
Arthritis 47%
Diabetes 28%
Ischemic heart disease 21%
Heart failure 20%
Chronic kidney disease 20%
Depression 19%
Atrial fibrillation 15%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 20 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Bimzelx
  • UCB, Inc. $200
$200 — —
COSENTYX
  • Novartis Pharmaceuticals Corporation $156
$156 21 —
TREMFYA
  • Janssen Biotech, Inc. $144
$144 — —
DUPIXENT
  • GENZYME CORPORATION $112
$112 12 —
VTAMA
  • Dermavant Sciences, Inc. $96
$96 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 20 in the dashboard with a free account

Records

237 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record